Search Results
Beat AML: John Byrd, M.D., OSUCCC
LLS Roundtable - Innovation in Research: Blood Cancers and Beyond, John Byrd, M.D.
BEAT AML: PERSONALIZED TREATMENT FOR DEADLY BLOOD AND BONE MARROW CANCER
Updates from the Beat AML Master Trial
Dr. Byrd on Resistance to Ibrutinib
Changing Cancer Patients’ Lives
Dr. John Byrd Discusses the Treatment Landscape for CLL
Dr. John Byrd on Challenges in CLL
Dr. Byrd Provides an Update on Ibrutinib in CLL
Beat AML: Dr. Druker, OHSU Knight Cancer Institute
Dr. Byrd on Challenges Facing CLL
Dr. Byrd Describes a Phase I/Ib Study of the CDK Inhibitor Dinaciclib in CLL
